| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.0M | +8.7% |
| SG&A Expense | $2.5M | +1673.4% |
| Operating Income | -$4.4M | -9.7% |
| Net Income | -$4.4M | -9.0% |
| EPS (Basic) | $0.29 | +11.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.3M | -61.9% |
| Current Assets | $2.4M | -61.0% |
| Total Assets | $2.4M | -61.1% |
| Current Liabilities | $1.0M | +14.7% |
| Total Liabilities | $1.2M | +8.8% |
| Stockholders' Equity | $1.2M | -76.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.7M | +1.1% |
| Capital Expenditures | $1K | -80.0% |
| Investing Cash Flow | $1K | +200.0% |
| Free Cash Flow | -$3.7M | +1.2% |